Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 3.5S - 13 mm: medical device reports filed with FDA

2,134 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

2,134
device reports naming the brand
0% of all MAUDE reports · about 301 a year
241
reports, 12 months to August 2026
337 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,134 reports that name the brand "OsseoSpeed TX 3.5S - 13 mm" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

241 reports arrived in the 12 months to August 2026, down 28% from 337 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (35.7%), loss of osseointegration (33.3%) and failure to osseointegrate (27.7%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02549Sep 2021: 26Oct 2021: 27Nov 2021: 35Dec 2021: 202022Jan 2022: 29Feb 2022: 14Mar 2022: 30Apr 2022: 39May 2022: 34Jun 2022: 21Jul 2022: 26Aug 2022: 23Sep 2022: 11Oct 2022: 16Nov 2022: 26Dec 2022: 232023Jan 2023: 21Feb 2023: 35Mar 2023: 16Apr 2023: 13May 2023: 25Jun 2023: 25Jul 2023: 37Aug 2023: 45Sep 2023: 30Oct 2023: 23Nov 2023: 26Dec 2023: 252024Jan 2024: 33Feb 2024: 28Mar 2024: 31Apr 2024: 28May 2024: 24Jun 2024: 22Jul 2024: 21Aug 2024: 39Sep 2024: 27Oct 2024: 31Nov 2024: 46Dec 2024: 202025Jan 2025: 22Feb 2025: 11Mar 2025: 49Apr 2025: 8May 2025: 25Jun 2025: 26Jul 2025: 41Aug 2025: 31Sep 2025: 24Oct 2025: 9Nov 2025: 18Dec 2025: 202026Jan 2026: 36Feb 2026: 23Mar 2026: 18Apr 2026: 20May 2026: 10Jun 2026: 21Jul 2026: 29Aug 2026: 13

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03276542019: 6320192021: 65420212022: 29220222023: 32120232024: 35020242025: 28420252026: 1702026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,134
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,134
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem76135.7%7.7%
Loss of osseointegration71133.3%22.4%
Failure to osseointegrate59227.7%62.8%
Fracturea broken bone854%1.6%
Crackthe device cracked80.4%0%
Loosening of implant not related to bone-ingrowth80.4%0.1%
Difficult to insertthe device was hard to insert10%0.4%
Off-label use10%0%
Positioning failure10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,133100%
Inflammationinflammation37917.8%
Pocket erosion1476.9%
Osteolysis1185.5%
Implant pain30.1%
Inadequate osseointegration30.1%
Painpain, site not specified20.1%
Erosion10%
Fistula10%
Impaired healingslow healing10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 3.5S - 13 mmProduct code DZEAll MAUDE reports
Reports2,1343,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 3.5S - 13 mm reports

How many FDA reports name OsseoSpeed TX 3.5S - 13 mm?

2,134 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 241 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (35.7%), loss of osseointegration (33.3%), failure to osseointegrate (27.7%), fracture (4%) and crack (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 3.5S - 13 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.